Title : Magnetic Resonance Spectroscopy in the Ventral Tegmental Area Distinguishes Responders to Suvorexant Prior to Treatment: A 4-Week Prospective Cohort Study.

Pub. Date : 2021

PMID : 34497544






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The present study examined the utility of magnetic resonance spectroscopy (MRS) for detecting neural and/or glial changes in the VTA to distinguish responders from non-responders before treatment with the orexin receptor antagonist suvorexant. suvorexant hypocretin neuropeptide precursor Homo sapiens